wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47688424-B529D307-3899-41C2-844D-16AA9906888F
Q47688424-B529D307-3899-41C2-844D-16AA9906888F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47688424-B529D307-3899-41C2-844D-16AA9906888F
Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithm.
P2860
Q47688424-B529D307-3899-41C2-844D-16AA9906888F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47688424-B529D307-3899-41C2-844D-16AA9906888F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b7c0891feabb7d433905f37a9cee0dd146a0a4ff
P2860
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.